Constellation Pharmaceuticals Lands $22,000,000 Series B Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f00f10e9-b226-4d8e-9dc2-aa36a26b3b3f&Preview=1
Date
6/2/2010
Company Name
Constellation Pharmaceuticals
Mailing Address
148 Sidney Street Cambridge, MA 02139
Company Description
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
Website
http://www.constellationpharma.com
Transaction Type
Venture Equity
Transaction Amount
$22,000,000
Transaction Round
Series B
Proceeds Purposes
Proceeds from the financing will be used to advance the development of Constellation’s pipeline of compounds towards the clinic. These funds will also enable Constellation to continue applying its innovative epigenetics product engine to probe multiple classes of novel drug targets involved in chromatin regulation and disease.
M&A Terms
Venture Investor
SR One
Venture Investor
Third Rock Ventures
Venture Investor
Venrock
Venture Investor
The Column Group
Venture Investor
Altitude Life Science Ventures